Abstract:Introduction: Many well-known risk factors for breast cancer are associated with dysbiosis (an aberrant microbiome). However, how bacterial products modulate cancer are poorly understood. In this study, we investigated the effect of an exopolysaccharide (EPS) produced by the commensal bacterium Bacillus subtilis on breast cancer phenotypes. Although B. subtilis is commonly included in probiotic preparations and its EPS protects against inflammatory diseases, it was virtually unknown whether B. subtilis-derived EPS affects cancer. Methods: This work investigated effects of EPS on phenotypes of breast cancer cells as a cancer model. The phenotypes included proliferation, mammosphere formation, cell migration, and tumor growth in two immune compromised mouse models. RNA sequencing was performed on RNA from four breast cancer cells treated with PBS or EPS. IKKβ or STAT1 signaling was assessed using pharmacologic or RNAi-mediated knock down approaches. Results: Short-term treatment with EPS inhibited proliferation of certain breast cancer cells (T47D, MDA-MB-468, HCC1428, MDA-MB-453) while having little effect on others (MCF-7, MDA-MB-231, BT549, ZR-75-30). EPS induced G1/G0 cell cycle arrest of T47D cells while increasing apoptosis of MDA-MB-468 cells. EPS also enhanced aggressive phenotypes in T47D cells including cell migration and cancer stem cell survival. Long-term treatment with EPS (months) led to resistance in vitro and promoted tumor growth in immunocompromised mice. RNA-sequence analysis showed that EPS increased expression of pro-inflammatory pathways including STAT1 and NF-κB. IKKβ and/or STAT1 signaling was necessary for EPS to modulate phenotypes of EPS sensitive breast cancer cells. Discussion: These results demonstrate a multifaceted role for an EPS molecule secreted by the probiotic bacterium B. subtilis on breast cancer cell phenotypes. These results warrant future studies in immune competent mice and different cancer models to fully understand potential benefits and/or side effects of long-term use of probiotics.

Study on Growth Inhibiting Effect of of Streptococcus thermophilus Exopolysaccharide from Tibetan Kefir on Human Colon Cancer Cells

Exopolysaccharides Produced by Lactobacillus Strains Suppress HT-29 Cell Growth Via Induction of G0/G1 Cell Cycle Arrest and Apoptosis

Antitumor mechanisms of an exopolysaccharide from Lactobacillus fermentum on HT-29 cells and HT-29 tumor-bearing mice

Effect of Exopolysaccharide from Bifidobacterium Bifidum on Cell of Gastric Cancer and Human Telomerase Reverse Transcriptase

Anti-tumor and Immunomodulatory Activities of an Exopolysaccharide from Rhizopus Nigricans on CT26 Tumor-Bearing Mice.

Evaluation The Antitumor Effects Of Exopolysaccharide Produced By Newly Isolated Bacillus Amyloliquefaciens Strain C-1

Exopolysaccharide from Trichoderma Pseudokoningii Induces the Apoptosis of MCF-7 Cells Through an Intrinsic Mitochondrial Pathway.

Effects of Rhizopus Nigricans Exopolysaccharide on Proliferation, Apoptosis, and Migration of Breast Cancer MCF-7 Cells and Akt Signaling Pathway

Exopolysaccharide from Weissella Confusa J4-1 Inhibits Colorectal Cancer Via Induction of Cell Cycle Arrest.

The effect of an exopolysaccharide probiotic molecule from Bacillus subtilis on breast cancer cells

The relationship between the structural characteristics of lactobacilli-EPS and its ability to induce apoptosis in colon cancer cells in vitro

Effects of PolyphyllinⅡ in Growth Inhibition of Human Breast Cancer Cells

Anticancer Potential of an Exopolysaccharide from Lactobacillus Helveticus MB2-1 on Human Colon Cancer HT-29 Cells Via Apoptosis Induction.

The anticancer mechanisms of exopolysaccharide from Weissella cibaria D-2 on colorectal cancer via apoptosis induction

Antitumor activity of an exopolysaccharide from Trichoderma pseudokoningii complexes car-rying 5-fluorouracil on CT26-tumor bearing mice

THE ANTITUMOUR AND IMMUNOMODULATING EFFECT OF EXOPOLYSACCHARIDES PRODUCED BY LACTOBACILLUS DELBRUECCKII SSP. BULGARICUS

The Inhibitory Effect of Polysaccharide from Rhizopus Nigricans on Colitis-Associated Colorectal Cancer.

An exopolysaccharide from Trichoderma pseudokoningii and its apoptotic activity on human leukemia K562 cells

Exopolysaccharides from Lactobacillus Plantarum NCU116 Induce C-Jun Dependent Fas/Fasl-mediated Apoptosis Via TLR2 in Mouse Intestinal Epithelial Cancer Cells

Inhibitory Effects of Exopolysaccharide(eps) from an Antarctic Psychrotrophs Pseudoalteromonas Sp.s-15-13 on the Sarcoma_(180) of Mice

[Immune Regulation Activity and Mechanism of Tibetan Kefir Exopolysaccharide Fractions].